Overview
Lung volume reduction surgery is an option for some people with severe, advanced emphysema, a type of chronic obstructive pulmonary disease (COPD). In these people, the lungs are hyperinflated and cannot… read more
Overview
Zephyr Valve insertion surgery is an option approved by the U.S. Food and Drug Administration (FDA) for some people with severe, advanced emphysema — a type of chronic obstructive pulmonary disease (COPD). In… read more
Overview
Lung transplant may be an option for some people with end-stage chronic obstructive pulmonary disease (COPD) who have tried every other avenue of treatment. Lung transplants may involve one (single-lung… read more
Overview
In people with chronic obstructive pulmonary disease (COPD), the structure of the lung weakens. The alveoli, tiny sacs of air where carbon dioxide is exchanged for oxygen, may become damaged. If the alveoli… read more
Overview
Brovana is a prescription drug first approved by the Food and Drug Administration (FDA) for long-term maintenance of bronchoconstriction in chronic obstructive pulmonary disease (COPD). Brovana is not… read more
Overview
Tudorza is a prescription drug approved by the Food and Drug Administration (FDA) for maintenance treatment of bronchospasm in chronic obstructive pulmonary disease (COPD). Tudorza is not indicated for rescue… read more
Overview
Striverdi Respimat is a prescription drug approved by the Food and Drug Administration (FDA) in 2014 for daily maintenance of bronchospasms in chronic obstructive pulmonary disease (COPD). Striverdi Respimat… read more
Overview
Arcapta is a prescription drug approved by the Food and Drug Administration (FDA) in 2011 for maintenance treatment of airflow obstruction in chronic obstructive pulmonary disease (COPD). Arcapta is not… read more
Overview
Serevent is a prescription drug approved by the Food and Drug Administration (FDA) to treat asthma and prevent bronchospasms in people age 4 and older with reversible obstructive airway problems such as chronic… read more
Overview
Perforomist is a prescription drug first approved by the Food and Drug Administration (FDA) in 2001 for maintenance of asthma and prevention of bronchospasms in chronic obstructive pulmonary disease (COPD).… read more